Member Center | Contact Us | Site Map | Archives | Photos | Alerts | Mobile Edition | Subscribe to the paper
 
Regeneron Pharmaceuticals, Inc.  REGN
  Growth Grade: A  
Fiscal year-end: 12  2009201020112012
Sales %  59.121.0-2.9209.2
Earnings/Share %  ------------
Book Value/Share %  -7.620.7-11.3144.6
Dividends/Share %  ------------
View company's forecasted earnings growth
       
 Profitability Grade: F  
Fiscal year-end: 12TTM=Trailing 12 Months
20082009201020112012TTM
Return on Assets %-9.5-9.3-11.4-18.444.146.2
Industry Rank2731344044
Return on Equity %-17.9-16.6-22.6-43.886.787.7
Industry Rank3740446944
Industry Rank (100=Worst) 
ROE Breakdown
Net Margin%-33.2-17.9-22.8-49.754.452.8
Asset Turnover0.30.50.50.40.80.9
Financial Leverage1.71.9---2.71.71.6
View company's full financials
 Financial Health Grade: B  
Fiscal year-end: 12Qtr = Current Quarter
20082009201020112012Qtr
Long-Term Debt $Mil---------275297302
Total Equity $Mil4223975284861,2451,406
Debt/Equity---0.3---0.90.40.3
S&P 5001.00.90.91.61.33.0
Financial Leverage1.71.9---2.71.71.6
S&P 5004.54.04.05.56.09.7
Current Ratio6.24.5---4.57.46.6
S&P 5001.82.01.81.81.81.8
View balance sheet
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2013 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.